Drug-labels.com

NTP-Pravastatin: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
10 mg, 20 mg, 40 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - NTP-Pravastatin

ABOUT THIS MEDICATION

What the medication is used for:

NTP-PRAVASTATIN is available only with your physician's prescription. It is to be used as an adjunct to a medically recommended and carefully supervised diet for the long-term treatment of hypercholesterolemia and is not a substitute for such a diet. This has been shown to decrease the chances of experiencing a first or second heart attack, or stroke, and may help prevent heart disease if caused by cholesterol clogging the blood vessels, or slow the progression of atherosclerosis (hardening) of the arteries that nourish your heart, so-called coronary heart disease (CHD). In addition, depending on your condition, your physician may recommend an appropriate regimen of exercise, weight control and other measures.

What it Does:

NTP-PRAVASTATIN lowers the level of cholesterol, particularly Low Density Lipoprotein (LDL) cholesterol, in the blood. NTP-PRAVASTATIN reduces cholesterol production by the liver and induces some changes of cholesterol transport and disposition in the blood and tissues.

When it should not be used:

  • If you are pregnant, since its use in the event of pregnancy may harm the unborn. Only female patients who are highly unlikely to conceive can be candidates for NTP-PRAVASTATIN treatment. In the event of pregnancy during treatment, NTP-PRAVASTATIN should be discontinued and the physician should be informed.
  • If you know that you are allergic to pravastatin or any of the non-medicinal ingredients of NTP-PRAVASTATIN.
  • If you have liver disease.

    • In adolescents and children since the safety of NTP-PRAVASTATIN in this age group has not been established.

What the medicinal ingredient is:

Pravastatin sodium

What the important non-medicinal ingredients are:

Lactose anhydrous, povidone, crospovidone, calcium phosphate dibasic anhydrous, sodium stearyl fumarate, microcrystalline cellulose, croscarmellose sodium, ferric oxide red (10 mg tablet), ferric oxide yellow (20 mg tablet), color yellow DC No.10 Aluminum Lake 18-24% and color FDC blue No.1 Aluminum Lake 11-13% (40 mg tablet).

What dosage forms it comes in:

10, 20 and 40 mg tablets

WARNINGS AND PRECAUTIONS

Use only as specifically directed. Do not alter the dosage unless ordered to do so by your physician. Check with your physician before discontinuing medication since this may result in an increase of your blood lipids.

Before taking NTP-PRAVASTATIN, tell your doctor or pharmacist if you:

  • are breast-feeding or intend to breast-feed,
  • have thyroid problems,
  • have a family history of muscular disorders,
  • had any past problems with the muscles (pain, tenderness), after using an HMG-CoA reductase inhibitor ("statin") such as atorvastatin (Lipitor®)3 fluvastatin (Lescol®)4, lovastatin (Mevacor®)5, pravastatin (NTP-PRAVASTATIN), rosuvastatin (Crestor®)6 or simvastatin (Zocor®)5, or have developed an allergy or intolerance to them,
  • have kidney or liver problems,
  • diabetes,
  • have undergone surgery or other tissue injury,
  • do excessive physical exercise.

Pregnancy

Before using this medication, discuss the following with your doctor:

3 Lipitor® is a registered trademark of Pfizer Ireland Pharmaceuticals.

4 Lescol® is a registered trademark of Sandoz Canada Inc. 5 Mevacor® and Zocor® are registered trademarks of Merck & Co., Inc.

6 Crestor® is a registered trademark of IPR Pharmaceuticals Inc.

  • Cholesterol compounds are essential elements for the development of a fetus.
  • Cholesterol-lowering drugs can harm the fetus. If you are of child-bearing age, discuss with your doctor the potential hazards to the fetus and the importance of birth control methods.
  • NTP-PRAVASTATIN should not be used by pregnant women. If you become pregnant, discontinue use immediately and discuss with your doctor.

INTERACTIONS WITH THIS MEDICATION

NTP-PRAVASTATIN may interact with other drugs, including those you take without a prescription. You must tell your doctor or pharmacist about all drugs, including prescription and nonprescription, herbal products and supplements, you are taking or planning to take before you take NTP-PRAVASTATIN.

You should tell your doctor if you are taking other cholesterol lowering medication such as fibrates (gemfibrozil, fenofibrate), niacin, or ezetimibe. If you take these drugs and NTP-PRAVASTATIN together, you may be at an increased risk of myopathy (muscle disease with aching or weakness).

If you are taking a bile acid-binding resin (such as cholestyramine, colestipol), your doctor will recommend that you take NTP-PRAVASTATIN either one hour or more before or at least four hours following the resin. Taking them together causes lower amounts of NTP-PRAVASTATIN in the blood, making it less effective.

If you are taking cyclosporine, your doctor may need to adjust the dose of NTP-PRAVASTATIN.

Excessive alcohol intake should be avoided when taking NTP-PRAVASTATIN. Tell your doctor if you regularly drink three or more alcoholic drinks daily.

PROPER USE OF THIS MEDICATION

  • Do not change the dose unless directed by a doctor.
  • NTP-PRAVASTATIN should be taken as a single dose at bedtime, as prescribed by your physician.
  • Your physician will monitor your clinical condition and your blood tests at regular intervals. It is important to have these check-ups done on schedule. Please keep your appointments accurately.
  • Notify your physician about any illness which may develop during your treatment with NTP-PRAVASTATIN and about any new prescription or non-prescription medication you may take. If you require medical help for other reasons, inform the

    attending physician that you are taking NTP-PRAVASTATIN,

    • Notify your physician if you are going to have major surgery or have sustained a severe injury,
    • Notify your physician of any muscle pain, tenderness or weakness developing during treatment with NTP-PRAVASTATIN (see SIDE EFFECTS AND WHAT TO DO ABOUT THEM).

Usual dose:

The recommended starting dose is 20 mg once daily at bed time. Patients who require a large dose reduction in LDL-C may be started at 40 mg once daily. The dose of 80 mg once daily should be reserved for patients who do not achieve their treatment goal with lower doses. NTP-PRAVASTATIN may be taken without regard to meals.

Overdose:

There is no specific recommended therapy for overdose with NTP-PRAVASTATIN.

In case of overdose, contact your doctor immediately or go to the nearest hospital emergency room.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Along with its intended action, any medication may cause unwanted effects.

Check with your physician as soon as possible if any of the following side effects occurs: aching muscles, muscle cramping, tiredness or weakness, fever and blurred vision.

Muscle effects

Side effects such as myalgia (muscle pain), myopathy (muscle disease with aching or weakness) , rhabdomyolosis (a muscle wasting disease), associated tenderness, and rare cases of rhabdomylosis leading to kidney failure have been reported with other drugs of this class, known as HMG-CoA reductase inhibitors ("statins"), including NTP-PRAVASTATIN.

As these muscle problems are on rare occasions serious, you should contact your physician promptly if you experience any of the side effects listed in the Table below.

Possible side effects reported with some statins: breathing problems including persistent cough and/or shortness of breath or fever, mood problems including depression, problems sleeping including insomnia and nightmares and sexual problems

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or

pharmacist

Stop taking

drug and

call your

doctor or pharmacist

Only if severeIn all cases
Rare

-muscle pain that you cannot explain

-muscle tenderness or muscle weakness -generalized

weakness, especially if you do not feel well (ie. fever or fatigue)

-brownish or

discoloured urine

X

X

X

X

Other side effects may occasionally occur which usually do not require stopping treatment. They may come and go during treatment without any particular danger, but you should mention them to your physician, without undue delay, if they become persistent or bothersome. Such adverse experiences include abdominal pain, constipation, diarrhea, nausea, headache, dizziness and skin rashes.

This is not a complete list of side effects. For any unexpected effects while taking NTP-PRAVASTATIN, contact your doctor or pharmacist.

HOW TO STORE IT

NTP-PRAVASTATIN should be stored at room temperature (15-30°C).

Protect from moisture and light.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

Report online at:

www.healthcanada.gc.ca/medeffect Call toll-free telephone: 1-866-234-2345 Complete a Canada Vigilance Reporting Form and

Fax toll free to: 1-866-678-6789; or Mail to: Canada Vigilance Program Health Canada

Postal Locator: 0701C Ottawa, ON, K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at: www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effect; contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting Teva Canada Ltd. at:

1-800-268-4127 (English)

1-877-777-9117 (French)

or druginfo@tevacanada.com

Teva Canada Ltd.

30 Novopharm Court

Toronto, Ontario

Canada, M1B 2K9

Last revised: July 23, 2013

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02345730

Revision date stated in the text: July 23, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for NTP-Pravastatin

Rx or OTC
Prescription (Rx)?
DIN 02345730, 02345749, 02345757
Schedule(s) PRESCRIPTION
Active ingredient(s) Pravastatin sodium
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AA HMG CoA reductase inhibitors, plain lipid modifying drugs
          1. C10AA03 Pravastatin
Company TEVA CANADA LIMITED
Current status Cancelled Pre Market
Current status date June 13, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02345730 10 MG Tablet Cancelled Pre Market June 13, 2017
02345749 20 MG Tablet Cancelled Pre Market June 13, 2017
02345757 40 MG Tablet Cancelled Pre Market June 13, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.